Phio Pharmaceuticals (PHIO) Institutional Ownership $1.67 -0.05 (-2.91%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.70 +0.03 (+1.80%) As of 02/21/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Phio Pharmaceuticals (NASDAQ:PHIO)CurrentInstitutional OwnershipPercentage57.31%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$73.64KNumber ofInstitutional Sellers(last 12 months)0 Get PHIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Phio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHIO Institutional Buying and Selling by Quarter Phio Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025 Virtu Financial LLC40,910$74K0.0%N/A0.594% 8/14/2023 Anson Funds Management LP22,571$65K0.0%N/A1.505% 8/10/2023 Cetera Investment Advisers10,666$31K0.0%N/A0.711% 8/2/2023 Bank of Montreal Can10,000$38K0.0%N/A0.667% 8/11/2022 Cetera Investment Advisers75,000$53K0.0%-16.7%0.549% 11/16/2021 Cetera Investment Advisers30,000$61K0.0%N/A0.222% 11/9/2021BlackRock Inc.35,592$72K0.0%-17.8%0.263% 9/17/2021 Virtu Financial LLC27,110$61K0.0%+74.7%0.200% 8/13/2021 Vanguard Group Inc.276,561$625K0.0%+125.4%2.043% 8/12/2021 Dimensional Fund Advisors LP23,960$54K0.0%-31.2%0.177% 5/19/2021 Virtu Financial LLC15,522$42K0.0%N/A0.115% 5/14/2021 Dimensional Fund Advisors LP34,808$93K0.0%+38.3%0.257% 5/12/2021 Geode Capital Management LLC87,501$234K0.0%+330.6%0.647% 5/10/2021 GSA Capital Partners LLP132,333$355K0.1%+30.5%0.978% 3/26/2021 Susquehanna International Group LLP12,058$32K0.0%N/A0.085% 3/8/2021 Dimensional Fund Advisors LP25,177$68K0.0%N/A0.178% 2/25/2021 Dimensional Fund Advisors LP25,177$68K0.0%N/A0.178% (Data available from 1/1/2016 forward) PHIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHIO shares? During the previous two years, the following institutional investors and hedge funds held shares of Phio Pharmaceuticals shares: Virtu Financial LLC ($74K), Anson Funds Management LP ($65K), and Bank of Montreal Can ($38K), Cetera Investment Advisers ($31K).Learn more on PHIO's institutional investors. What percentage of Phio Pharmaceuticals stock is owned by institutional investors? 57.31% of Phio Pharmaceuticals stock is owned by institutional investors. Learn more on PHIO's institutional investor holdings. Which institutional investors have been buying Phio Pharmaceuticals stock? The following institutional investors have purchased Phio Pharmaceuticals stock in the last 24 months: Virtu Financial LLC ($40.91K), Anson Funds Management LP ($22.57K), Cetera Investment Advisers ($10.67K), and Bank of Montreal Can ($10K). How much institutional buying is happening at Phio Pharmaceuticals? Institutional investors have bought a total of 84,147 shares in the last 24 months. This purchase volume represents approximately $1.19M in transactions. Related Companies FGEN Institutional Ownership IMMX Institutional Ownership LTRN Institutional Ownership RPTX Institutional Ownership PRLD Institutional Ownership KALA Institutional Ownership CNTB Institutional Ownership CELU Institutional Ownership XLO Institutional Ownership DYAI Institutional Ownership This page (NASDAQ:PHIO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phio Pharmaceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
